Tianyin Pharmaceutical (TPI) Reports Q2 EPS of $0.06, Provides Outlook
Tweet Send to a Friend
Tianyin Pharmaceutical (NYSE: TPI) reported Q2 EPS of $0.06, versus $0.06 reported last year. Revenue for the quarter came in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
